Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
BCRX holding history
Biocryst Pharmaceuticals Inc in every 13F filed by Eversept Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BCRX overviewAll 13F holders of BCRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,865,653
- Value
- $18.7M
- % of portfolio
- 1.0%
- Quarters held
- 15
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,865,653 | $18.7M | 1.0% | −1,174,167−38.6% | Reduced | Holders |
| Q1 2026 | 3,039,820 | $28.9M | 1.9% | +46,925+1.6% | Added | Holders |
| Q4 2025 | 2,992,895 | $23.3M | 1.3% | +1,619,270+117.9% | Added | Holders |
| Q3 2025 | 1,373,625 | $10.4M | 0.8% | +165,987+13.7% | Added | Holders |
| Q2 2025 | 1,207,638 | $10.8M | 1.1% | −964,798−44.4% | Reduced | Holders |
| Q1 2025 | 2,172,436 | $16.3M | 1.8% | +192,124+9.7% | Added | Holders |
| Q4 2024 | 1,980,312 | $14.9M | 1.5% | +1,444,907+269.9% | Added | Holders |
| Q3 2024 | 535,405 | $4.07M | 0.3% | −617,168−53.5% | Reduced | Holders |
| Q2 2024 | 1,152,573 | $7.12M | 0.5% | −279,854−19.5% | Reduced | Holders |
| Q1 2024 | 1,432,427 | $7.28M | 0.5% | −96,620−6.3% | Reduced | Holders |
| Q4 2023 | 1,529,047 | $9.16M | 0.9% | −950,056−38.3% | Reduced | Holders |
| Q3 2023 | 2,479,103 | $17.6M | 1.9% | +106,990+4.5% | Added | Holders |
| Q2 2023 | 2,372,113 | $16.7M | 1.8% | −2,148,611−47.5% | Reduced | Holders |
| Q1 2023 | 4,520,724 | $37.7M | 3.4% | +3,640,237+413.4% | Added | Holders |
| Q4 2022 | 880,487 | $10.1M | 1.0% | +880,487 | New | Holders |